Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) EBT Margin (2016 - 2025)

Marimed (MRMD) has disclosed EBT Margin for 15 consecutive years, with 0.45% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin rose 38.0% to 0.45% in Q3 2025 year-over-year; TTM through Sep 2025 was 4.2%, a 235.0% increase, with the full-year FY2024 number at 2.51%, up 193.0% from a year prior.
  • EBT Margin was 0.45% for Q3 2025 at Marimed, up from 1.46% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 35.01% in Q2 2021 to a low of 24.76% in Q4 2023.
  • A 5-year average of 5.41% and a median of 2.47% in 2021 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: surged 5351bps in 2021, then crashed -3245bps in 2023.
  • Marimed's EBT Margin stood at 2.47% in 2021, then skyrocketed by 211bps to 7.69% in 2022, then plummeted by -422bps to 24.76% in 2023, then skyrocketed by 66bps to 8.34% in 2024, then soared by 95bps to 0.45% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's EBT Margin are 0.45% (Q3 2025), 1.46% (Q2 2025), and 6.82% (Q1 2025).